Bioadaptives, Inc. (BDPT) Gains from Investment Securities (2021 - 2023)

Bioadaptives has reported Gains from Investment Securities for 3 years, with the latest figure at -$261488.0 in Q3 2023.

• Quarterly Gains from Investment Securities fell 337.26% year-over-year to -$261488.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$97208.0 (down 154.38% YoY) and the FY2022 annual result came in at $184401.0, up 104.39% from the prior year.
• Gains from Investment Securities retreated to -$261488.0 in Q3 2023 per BDPT's latest filing, from $35705.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $217139.0 in Q1 2023 and troughed at -$261488.0 in Q3 2023.
• A 3-year average of -$15218.4 and a median of -$26429.5 in 2022 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities jumped 154.21% in 2022, then sank 337.26% in 2023.
• Over 3 years, Gains from Investment Securities stood at -$94201.0 in 2021, then rose by 5.98% to -$88564.0 in 2022, then tumbled by 195.25% to -$261488.0 in 2023.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$261488.0, $35705.0, and $217139.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.